Skye Bioscience Ownership | Who Owns Skye Bioscience?
Skye Bioscience Ownership Summary
Skye Bioscience is owned by 32.23% institutional investors, 1.44% insiders, and 66.33% retail investors.
SKYE Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Skye Bioscience | 32.23% | 1.44% | 66.33% |
Sector | Healthcare Stocks | 278.45% | 10.60% | -189.04% |
Industry | Biotech Stocks | 63.84% | 10.66% | 25.50% |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Mar 31, 2025 | 74 | 2.78% | 12,779,599 | -49.30% | 32 | 0.68% | 29 | -29.27% | 19 | 111.11% |
Dec 31, 2024 | 72 | -4.00% | 25,208,445 | -2.03% | 69 | 1.57% | 41 | - | 9 | -10.00% |
Sep 30, 2024 | 75 | 17.19% | 25,730,090 | 5.03% | 66 | 1.65% | 41 | -31.67% | 10 | - |
Jun 30, 2024 | 64 | 2033.33% | 24,496,734 | 1119.17% | 63 | 123.02% | 60 | 2900.00% | - | - |
Mar 31, 2024 | 3 | 200.00% | 2,009,303 | 125481.44% | 7 | 1378182.02% | 2 | 100.00% | - | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Nov 18, 2024 | ARSENAULT KAITLYN | Chief Financial Officer | Sell | $214.70K |
Nov 15, 2024 | ARSENAULT KAITLYN | Chief Financial Officer | Sell | $1.05K |
Nov 15, 2024 | Diep Tuan Tu | Chief Development Officer | Sell | $471.75 |
Nov 18, 2024 | Diep Tuan Tu | Chief Development Officer | Sell | $97.25K |
Nov 15, 2024 | ARSENAULT KAITLYN | Chief Financial Officer | Sell | $1.05K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q2 | - | - |
2025 Q1 | - | - |
2024 Q4 | - | 10 |
2024 Q3 | - | 12 |
2024 Q1 | 2 | - |
SKYE Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools